Ameriprise
ELOS

Ameriprise’s Syneron Medical Ltd ELOS Stock Holding History

Ameriprise’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-208,434
Closed -$2.28M – 3841
2017
Q2 		$2.28M Sell
208,434
-73,953
-26% -$811K ﹤0.01% 2537
2017
Q1 		$2.98M Sell
282,387
-64,110
-19% -$620K ﹤0.01% 2394
2016
Q4 		$2.92M Buy
346,497
+9,901
+3% +$77.6K ﹤0.01% 2437
2016
Q3 		$2.41M Sell
336,596
-127,598
-27% -$887K ﹤0.01% 2467
2016
Q2 		$3.57M Sell
464,194
-14,790
-3% -$105K ﹤0.01% 2180
2016
Q1 		$3.5M Sell
478,984
-52,550
-10% -$376K ﹤0.01% 2199
2015
Q4 		$4.1M Buy
531,534
+111,783
+27% +$852K ﹤0.01% 2175
2015
Q3 		$3M Buy
419,751
+134,047
+47% +$1.29M ﹤0.01% 2366
2015
Q2 		$3.03M Buy
285,704
+78,183
+38% +$915K ﹤0.01% 2490
2015
Q1 		$2.57M Hold
207,521
– – ﹤0.01% 2467
2014
Q4 		$1.94M Buy
207,521
+46,740
+29% +$451K ﹤0.01% 2581
2014
Q3 		$1.61M Buy
+160,781
New +$1.64M ﹤0.01% 2598
2013
Q3 		– Sell
-120
Closed -$1K – 5726
2013
Q2 		$1K Buy
+120
New +$1.07K ﹤0.01% 5445

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Ameriprise's ELOS Position: Q3 2017 in Review

Ameriprise sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 208,434 shares — an estimated $2.28M sold.

Ameriprise first reported a position in ELOS in Q2 2013 and held it in 13 quarters. The position peaked at $4.1M in Q4 2015. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Ameriprise reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Ameriprise sold 208,434 Syneron Medical Ltd shares in Q3 2017, an estimated $2.28M.
  • Ameriprise first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 13 quarters.
  • Ameriprise's Syneron Medical Ltd position peaked at $4.1M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Ameriprise's 13F filing for Q3 2017, filed 7 Nov 2017.